MicroRNA-375 is a therapeutic target for castration-resistant prostate cancer through the PTPN4/STAT3 axis

MLA

Junqing Gan, et al. “MicroRNA-375 Is a Therapeutic Target for Castration-Resistant Prostate Cancer through the PTPN4/STAT3 Axis.” Experimental and Molecular Medicine, vol. 54, no. 8, Aug. 2022, pp. 1290–305. EBSCOhost, https://doi.org/10.1038/s12276-022-00837-6.

APA

Junqing Gan, Shan Liu, Yu Zhang, Liangzi He, Lu Bai, Ran Liao, Juan Zhao, Madi Guo, Wei Jiang, Jiade Li, Qi Li, Guannan Mu, Yangjiazi Wu, Xinling Wang, Xingli Zhang, Dan Zhou, Huimin Lv, Zhengfeng Wang, Yanqiao Zhang, … Xiaoyi Huang. (2022). MicroRNA-375 is a therapeutic target for castration-resistant prostate cancer through the PTPN4/STAT3 axis. Experimental and Molecular Medicine, 54(8), 1290–1305. https://doi.org/10.1038/s12276-022-00837-6

Chicago

Junqing Gan, Shan Liu, Yu Zhang, Liangzi He, Lu Bai, Ran Liao, Juan Zhao, et al. 2022. “MicroRNA-375 Is a Therapeutic Target for Castration-Resistant Prostate Cancer through the PTPN4/STAT3 Axis.” Experimental and Molecular Medicine 54 (8): 1290–1305. doi:10.1038/s12276-022-00837-6.